Filing Details
- Accession Number:
- 0001209191-17-013117
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 15:34:09
- Reporting Period:
- 2017-02-19
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 15:34:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1415336 | Zeltiq Aesthetics Inc | ZLTQ | Electromedical & Electrotherapeutic Apparatus (3845) | 270119051 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1662139 | Bradley Hauser | C/O Zeltiq Aesthetics, Inc. 4410 Rosewood Drive Pleasanton CA 94588 | Svp, Research And Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-19 | 1,399 | $55.67 | 49,301 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-02-21 | 3,000 | $55.64 | 46,301 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents the number of shares withheld by and surrendered to the Issuer on February 19, 2017, to satisfy tax withholding obligations that arose in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on February 29, 2016 for 14,019 shares. The RSUs vest annually at a rate of 25% per year beginning from February 19, 2016, subject to the Reporting Person's continued service to the Issuer.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.61 to $55.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.